Add a listing
    Add a listing

    NewLimit

      inventing medicines composed of epigenetic reprogramming factors that restore youthful function in old cells.

    General
    • Headquarters

      Redwood City, California, United States

    • Founders & Team

      Brian Armstrong, Blake Byers

    • Year Founded

      2021

    • Company type

      Private company

    • Total funding ($M)

      105

    Technical Details
    • Aging Target

      Epigenetic alterations, Cellular senescence

    About

    NewLimit is inventing medicines composed of epigenetic reprogramming factors that restore youthful function in old cells. We leverage functional assays, single cell multi-omics, and machine learning to reveal epigenetic features of aging and discover rejuvenating interventions.

    NewLimit was founded by Coinbase CEO/Founder Brian Armstrong and Blake Byers (Google Ventures).

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In